<DOC>
	<DOCNO>NCT00584779</DOCNO>
	<brief_summary>To confirm pharmacokinetics follow administration gabapentin Japanese subject renal impairment , compare result Western study result confirm adaptive possibility dose adjustment US package insert Japanese .</brief_summary>
	<brief_title>An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis</brief_title>
	<detailed_description>The study terminate September 30 , 2008 current study site due report adverse event study subject ( n=8 ) . While adverse event report generally consistent know profile gabapentin , decide study continue different study site . The pharmacokinetics gabapentin subject renal impairment evaluate separate study different study number different site . The study entitle : `` The Pharmacokinetic Study Gabapentin Japanese Epileptic Subjects Renal Impairment '' .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>The subject whose creatinine clearance 559 mL/min , hemodialysis patient . The hemodialysis patient enter study require hemodialysis least six week ( frequency three time per week ) Renal allograft recipient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Gabapentin Pharmacokinetics , renal impairment</keyword>
</DOC>